Tissue Kallikrein Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the B2R-ERK1/2-CREB-Bcl-2 Signaling Pathway in Diabetic Rats

Figure 2

(a) NSS values recorded for each animal at 24 h after MCAO. rats/group. (b) Brain edema recorded in each animal at 24 h after MCAO. Data are expressed as mean ± SD; rats/group. (c) 2,3,5-Triphenyltetrazolium chloride staining recorded in nine groups at 24 h after MCAO; (d) the infarct volume percent at 24 h after MCAO. Data are expressed as mean ± SD; rats/group ( versus sham group; versus saline group; versus TK group; versus B1RA+TK group; versus B2RA+TK group).

(a)

(b)

(c)

(d)